Suppr超能文献

利用血小板和淋巴母细胞系简化梅里特系统的B细胞抗血清

Simplification of B-cell antisera of the Merrit system with platelets and lymphoblastoid cell lines.

作者信息

Naeim F, Gregg B, Gatti R A, Leibold W, Walford R L

出版信息

Transplant Proc. 1977 Mar;9(1):439-44.

PMID:68582
Abstract

Human sera with anti-HLA and anti-Merrit B-cell reactivities were absorbed with different volumes of a pool of packed outdated human platelets obtained from 237 donors. After absorption, each serum was tested against a panel of CLL cells and normal unfractionated peripheral blood lymphocytes that had given positive reactions with the same serum prior to absorption. The optimal platelet volume for complete absorption of anti-HLA and full preservation of anti-Merrit B-cell activities in these sera was found to be 1/10 to 1/5 of the volume of serum. Higher volumes of packed platelets, especially over 1/1, in most instances reduced anti-B-cell activity "nonspecifically." Among the platelet absorbed sera, those showing no HLA and strong anti-Merrit B-cell cytotoxicity were used for cross-absorption studies with cultured human lymphoid cell lines. Multi-specific anti-Merrit sera could be simplified by this method. Cultured lymphoblastoid cell lines represent a valuable resource, since large volumes of cells may be needed for absorption and simplification of human sera containing allogeneic B-lymphocyte antibodies.

摘要

将含有抗HLA和抗梅里特B细胞反应性的人血清,用从237名献血者获得的不同体积的一批过期人浓缩血小板进行吸收处理。吸收后,将每种血清与一组慢性淋巴细胞白血病细胞和正常未分离的外周血淋巴细胞进行检测,这些细胞在吸收前与同一份血清反应呈阳性。发现对于这些血清中抗HLA的完全吸收和抗梅里特B细胞活性的充分保留,最佳血小板体积为血清体积的1/10至1/5。在大多数情况下,更高体积的浓缩血小板,特别是超过1/1时,会“非特异性地”降低抗B细胞活性。在血小板吸收后的血清中,那些无HLA且具有强抗梅里特B细胞细胞毒性的血清用于与培养的人淋巴样细胞系进行交叉吸收研究。通过这种方法可以简化多特异性抗梅里特血清。培养的淋巴母细胞系是一种宝贵的资源,因为吸收和简化含有同种异体B淋巴细胞抗体的人血清可能需要大量细胞。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验